One of the most influential factors in science and medicine has been the development of placebo-controlled clinical trials. Rojavin, Mikhail A Downs, Pamela Shetzline, Michael A Chilingerian, Raffy Cohard-Radice, Marielle PMID:11825287įactors motivating dyspepsia patients to enter clinical research. Information technologies play a key role in these efforts. The results support the assertion that human factors research can make important contributions to patient safety. A novel concept of "non-routine events" is introduced and pilot data are presented.
This paper describes data obtained recently using task analysis and workload assessment during actual patient care and the use of cognitive task analysis to study clinical decision making. These techniques have increasingly been applied to the anesthesia work environment. Human factors research in other high-risk fields has demonstrated how rigorous study of factors that affect job performance can lead to improved outcome and reduced errors after evidence-based redesign of tasks or systems. Patient safety has become a major public concern. Human factors research in anesthesia patient safety. A novel concept of “non-routine events†is introduced and pilot data are presented.
Human Factors Research in Anesthesia Patient Safety However, we do not believe this should be an absolute contraindication for transplantation. The combination of various risk factors clearly worsened outcomes. The presence of certain risk factors in patients undergoing HT resulted in lower survival rates. Survival at 10 years, if fewer than two risk factors were present, was 69% 59% if two or three factors were present and 37% if more than three associated risk factors were present (P =. Overall patient survival at 1, 5, 10, and 13 years was 76%, 68%, 54%, and 47%, respectively.
Survival curves by number of risk factors using Kaplan-Meier and log-rank for comparison of curves. The results showed that: (1) The FVIIa, FVII:C and FVIIAg levels in chronic uremic patients before hemodialysis were 4.00 +/- 0.86 microg/L, (148.5 +/- 40.4)% and (99.8 +/- 21.1)% respectively, which were significantly increased, as compared with healthy controls [2.77 +/- 1.02 microg/L, (113.1 +/- 33.0)% and (73.7 +/- 18.3)% respectively, P 25), dyslipidemia, hypertension, prior thoracic surgery, diabetes, and history of ischemic heart disease. The plasma levels of coagulation factor VII were detected in 30 uremic patients with chronic renal failure before and after hemodialysis for 1 month, the factor VII activity (FVII:C) was determined by one-stage coagulation method, while activated factor VII (FVIIa) was measured by one-stage coagulation method using recombinant soluble tissue factor, and factor VII antigen was detected by ELISA. This study was aimed to investigate coagulation factor VII level in uremic patients with chronic renal failure and to explore theirs influence factors. įang, Jun Xia, Ling-Hui Wei, Wen-Ning Song, Shan-Jun